PLSI Stock: Phoenix Life Sciences International Limited Stock Price, Analysis & Insights
Get live PLSI stock price $0.00, comprehensive Phoenix Life Sciences International Limited stock analysis, charts, news, and expert forecast. Real-time PLSI stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Phoenix Life Sciences International Limited operates as a global healthcare solutions provider, conducting business in the United States and internationally. The company primarily concentrates on pioneering research, developing integrated programs, a...
Company Information
- CEO
- Willis Victory
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5
Contact Information
- Website
- https://www.phoenixlife.co
- Address
- 4262 Blue Diamond Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 204.07)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Phoenix Life Sciences International Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Phoenix Life Sciences International Limited
- ⚠Investors should consider how Phoenix Life Sciences International Limited fits within their overall portfolio allocation
Market Cap
365.91K
Beta
204.07
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PLSI with peer companies:
- Price
- $0.00
- Market cap
- 377.40K
- Price
- $0.00
- Market cap
- 74.57K
- Price
- $0.01
- Market cap
- 398.25K
- Price
- $0.00
- Market cap
- 377.35K
- Price
- $0.00
- Market cap
- 475.34K
- Price
- $0.01
- Market cap
- 458.85K
- Price
- $0.01
- Market cap
- 329.66K
- Price
- $0.07
- Market cap
- 529.97K
- Price
- $0.00
- Market cap
- 227.44K
- Price
- $0.01
- Market cap
- 295.93K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.